Kundakci Burak, Jones Katherine Louise, Booth Andrew, Parslow Roxanne M, Moore Andrew J, Gibbison Ben, Pufulete Maria
Sheffield Centre for Health and Related Research (SCHARR), The University of Sheffield, Sheffield, UK.
Centre for Musculoskeletal Research, The University of Manchester, Manchester, UK.
BMJ Open. 2025 Apr 28;15(4):e093338. doi: 10.1136/bmjopen-2024-093338.
Delirium is a common and serious condition that frequently affects patients in the intensive care unit (ICU). It is characterised by an acute disturbance in cognition, attention and awareness that develops over a short period of time and tends to fluctuate in severity. Patients with ICU delirium (ICUD) may experience confusion, disorientation, difficulty focusing and perceptual disturbances such as hallucinations or delusions. The prevalence of ICUD is high, with estimates suggesting that it can affect up to 70% of ICU patients. The development of ICUD is associated with several adverse outcomes, including prolonged ICU and hospital stays, increased healthcare costs, higher mortality rates and an increased risk of long-term cognitive impairment, including dementia. It is unclear which components should be included in a complex intervention to prevent and manage ICUD. Furthermore, we need to understand how the different components have been implemented and their impact on clinical practice.
The review will be reported according to the Preferred Reporting Items for Systematic reviews and Meta-Analysis Protocols (PRISMA-P) and the enhancing transparency in reporting the synthesis of qualitative research (ENTREQ) reporting recommendations. We will perform systematic searches to identify relevant interventions and implementation strategies for the prevention or management of ICUD. We will assess primary research, service evaluations and audits for the use of the Standards for QUality Improvement Reporting Excellence (SQUIRE) as a checklist for quality improvement in healthcare. We will extract both qualitative and quantitative data and assess study quality using the Critical Appraisal Skills Programme (CASP) tool. Our findings will be synthesised using a best-fit framework synthesis mapped against the Theoretical Domains Framework (TDF). Our Patient and Public Involvement (PPI) group will contribute to the development of review processes such as the research question and methodology and will help to evaluate which outcomes are most important.
No ethical approval is required for this study. The results of this systematic review of implementation strategies will be disseminated through peer-reviewed publications and conferences. They will also form part of an evidence map and logic model for factors that can improve the implementation of strategies for prevention, identification and management of ICUD.
CRD42024537313.
谵妄是一种常见且严重的病症,经常影响重症监护病房(ICU)的患者。其特征是在短时间内出现急性认知、注意力和意识障碍,且严重程度往往会波动。患有ICU谵妄(ICUD)的患者可能会出现困惑、定向障碍、注意力集中困难以及幻觉或妄想等感知障碍。ICUD的患病率很高,据估计,它可能影响多达70%的ICU患者。ICUD的发生与多种不良后果相关,包括ICU和住院时间延长、医疗费用增加、死亡率升高以及长期认知障碍(包括痴呆)风险增加。目前尚不清楚在预防和管理ICUD的复杂干预措施中应包括哪些组成部分。此外,我们需要了解不同组成部分是如何实施的以及它们对临床实践的影响。
本综述将按照系统评价和Meta分析方案的首选报告项目(PRISMA-P)以及定性研究综合报告的透明度增强(ENTREQ)报告建议进行报告。我们将进行系统检索,以确定预防或管理ICUD的相关干预措施和实施策略。我们将使用卓越质量改进报告标准(SQUIRE)作为医疗保健质量改进的清单,对原始研究、服务评估和审计进行评估。我们将提取定性和定量数据,并使用批判性评估技能计划(CASP)工具评估研究质量。我们的研究结果将使用与理论领域框架(TDF)相对应的最佳拟合框架综合法进行综合。我们的患者和公众参与(PPI)小组将为研究问题和方法等综述过程的制定做出贡献,并将有助于评估哪些结果最为重要。
本研究无需伦理批准。本实施策略系统评价的结果将通过同行评审的出版物和会议进行传播。它们还将成为证据地图和逻辑模型的一部分,该模型涉及可改善ICUD预防、识别和管理策略实施的因素。
PROSPERO注册号:CRD42024537313。